Cannabis-Based Drug (Still) Helps Epilepsy, but How Safe Is It?

Check off another positive clinical trial for GW Pharmaceuticals (NASDAQ: GWPH). Yesterday the company announced that its cannabis-based drug, Epidiolex, passed a phase 3 study testing the drug in a rare epileptic disease called Dravet syndrome.